-
Je něco špatně v tomto záznamu ?
TLR2 in pleural fluid is modulated by talc particles during pleurodesis
K. Jankovicova, K. Kondelkova, P. Habal, C. Andrys, J. Krejsek, J. Mandak,
Jazyk angličtina Země Egypt
Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2003
Free Medical Journals
od 1990
PubMed Central
od 2003 do 2013
Europe PubMed Central
od 2003 do 2013
Open Access Digital Library
od 2003-01-01 do 2013-12-31
Open Access Digital Library
od 2003-01-01 do 2013-12-31
Open Access Digital Library
od 2003-01-01
Medline Complete (EBSCOhost)
od 2003-03-01 do 2013-01-31
ROAD: Directory of Open Access Scholarly Resources
od 2003 do 2013
PubMed
23304186
DOI
10.1155/2012/158287
Knihovny.cz E-zdroje
- MeSH
- granulocyty účinky léků metabolismus MeSH
- insuflace metody MeSH
- lidé MeSH
- maligní pleurální výpotek metabolismus terapie MeSH
- mastek aplikace a dávkování MeSH
- pleura účinky léků metabolismus MeSH
- pleurodéza metody MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- senioři MeSH
- toll-like receptor 2 metabolismus MeSH
- torakoskopie metody MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- práce podpořená grantem MeSH
The aim of this study was to examine the role of TLR2 molecule in pleural space during thoracoscopic talc pleurodesis period in patients with malignant pleural effusion. We analyzed TLR2 molecule in soluble form as well as on membrane of granulocytes in pleural fluid. Pleural fluid examination was done at three intervals during pleurodesis procedure: 1st-before the thoracoscopic procedure, 2nd-2 hours after the terminating thoracoscopic procedure with talc insufflation, 3rd-24 hours after the thoracoscopic procedure. We reported significant increase of soluble TLR2 molecule in pleural fluid effusion during talc pleurodesis from preoperative value. This increase was approximately 8-fold in the interval of 24 hours. The changes on granulocyte population were quite different. The mean fluorescent intensity of membrane TLR2 molecule examined by flow cytometry on granulocyte population significantly decreased after talc exposure with comparison to prethoracoscopic density. To estimate the prognostic value of TLR2 expression in pleural fluid patients were retrospectively classified into either prognostically favourable or unfavourable groups. Our results proved that patients with favourable prognosis had more than 3-fold higher soluble TLR2 level in pleural fluid early, 2 hours after talc pleurodesis intervention.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031725
- 003
- CZ-PrNML
- 005
- 20131004094104.0
- 007
- ta
- 008
- 131002s2012 ua f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2012/158287 $2 doi
- 035 __
- $a (PubMed)23304186
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ua
- 100 1_
- $a Jankovicova, Karolina $u Department of Clinical Immunology and Allergy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University in Prague, Sokolska Street 581, 500 05 Hradec Kralove, Czech Republic. karolina.jankovicova@fnhk.cz
- 245 10
- $a TLR2 in pleural fluid is modulated by talc particles during pleurodesis / $c K. Jankovicova, K. Kondelkova, P. Habal, C. Andrys, J. Krejsek, J. Mandak,
- 520 9_
- $a The aim of this study was to examine the role of TLR2 molecule in pleural space during thoracoscopic talc pleurodesis period in patients with malignant pleural effusion. We analyzed TLR2 molecule in soluble form as well as on membrane of granulocytes in pleural fluid. Pleural fluid examination was done at three intervals during pleurodesis procedure: 1st-before the thoracoscopic procedure, 2nd-2 hours after the terminating thoracoscopic procedure with talc insufflation, 3rd-24 hours after the thoracoscopic procedure. We reported significant increase of soluble TLR2 molecule in pleural fluid effusion during talc pleurodesis from preoperative value. This increase was approximately 8-fold in the interval of 24 hours. The changes on granulocyte population were quite different. The mean fluorescent intensity of membrane TLR2 molecule examined by flow cytometry on granulocyte population significantly decreased after talc exposure with comparison to prethoracoscopic density. To estimate the prognostic value of TLR2 expression in pleural fluid patients were retrospectively classified into either prognostically favourable or unfavourable groups. Our results proved that patients with favourable prognosis had more than 3-fold higher soluble TLR2 level in pleural fluid early, 2 hours after talc pleurodesis intervention.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a granulocyty $x účinky léků $x metabolismus $7 D006098
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a insuflace $x metody $7 D007327
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pleura $x účinky léků $x metabolismus $7 D010994
- 650 _2
- $a maligní pleurální výpotek $x metabolismus $x terapie $7 D016066
- 650 _2
- $a pleurodéza $x metody $7 D018700
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a mastek $x aplikace a dávkování $7 D013627
- 650 _2
- $a torakoskopie $x metody $7 D013906
- 650 _2
- $a toll-like receptor 2 $x metabolismus $7 D051195
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kondelkova, Katerina $u -
- 700 1_
- $a Habal, Petr $u -
- 700 1_
- $a Andrýs, Ctirad $u - $7 mzk2008430528
- 700 1_
- $a Krejsek, Jan $u -
- 700 1_
- $a Mandak, Jiri $u -
- 773 0_
- $w MED00013777 $t Clinical & developmental immunology $x 1740-2530 $g Roč. 2012(2012), s. 158287
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23304186 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20131004094623 $b ABA008
- 999 __
- $a ok $b bmc $g 995812 $s 830170
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 2012 $d 158287 $i 1740-2530 $m Clinical & developmental immunology $n Clin Dev Immunol $x MED00013777
- LZP __
- $a Pubmed-20131002